We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.22 | -6.1797752809 | 3.56 | 3.78 | 3.23 | 178443 | 3.47920538 | CS |
4 | 0.36 | 12.0805369128 | 2.98 | 4.2684 | 2.88 | 305481 | 3.6551268 | CS |
12 | 1.7 | 103.658536585 | 1.64 | 4.2684 | 1.63 | 172090 | 3.11255557 | CS |
26 | 1.28 | 62.1359223301 | 2.06 | 4.2684 | 1.555 | 114112 | 2.72407071 | CS |
52 | 1.63 | 95.3216374269 | 1.71 | 4.2684 | 1.28 | 84195 | 2.38264869 | CS |
156 | -1.09 | -24.60496614 | 4.43 | 4.57 | 1.02 | 304051 | 3.11057714 | CS |
260 | -1.1 | -24.7747747748 | 4.44 | 5.7 | 1.02 | 398355 | 3.02310324 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions